1-3 of 3
Paola Sammuri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Gabriele Buda, MD PhD, Rita Fazzi, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Paola Sammuri, Enrico Orciuolo, MD PhD, Iacopo Petrini, Fabrizio Accardi, MD, Laura Notarfranchi, MD, Nicola Giuliani, Mario Petrini
Journal: Blood
Blood (2016) 128 (22): 5697.
https://doi.org/10.1182/blood.V128.22.5697.5697
Published: 2016
Journal Articles

CD69 Expression Predicts Favorable Outcome in Multiple Myeloma Patients Treated with VTD

Gabriele Buda, MD, Giovanni Carulli, Enrico Orciuolo, Paola Sammuri, Sara Galimberti, MD, Martina Rousseau, MD, Francesca Martini, Mario Petrini
Journal: Blood
Blood (2015) 126 (23): 1768.
https://doi.org/10.1182/blood.V126.23.1768.1768
Published: 2015
Journal Articles

CD69, a New Potential Clinical Marker in Multiple Myeloma

Gabriele Buda, MD, Giovanni Carulli, Enrico Orciuolo, Paola Sammuri, Daniele Campa, PhD, Sara Galimberti, Mario Petrini, MD
Journal: Blood
Blood (2014) 124 (21): 2027.
https://doi.org/10.1182/blood.V124.21.2027.2027
Published: 2014